Topics
News
CME/CE
Editorial Advisory Board
Partners
Subscribe
- Case-Based Roundtable
- General Dermatology
- Eczema
- Chronic Hand Eczema
- Alopecia
- Aesthetics
- Vitiligo
- COVID-19
- Actinic Keratosis
- Precision Medicine and Biologics
- Rare Disease
- Wound Care
- Rosacea
- Psoriasis
- Psoriatic Arthritis
- Atopic Dermatitis
- Melasma
- NP and PA
- Skin Cancer
- Hidradenitis Suppurativa
- Drug Watch
- Pigmentary Disorders
- Acne
- Pediatric Dermatology
- Practice Management
- Prurigo Nodularis
- Buy-and-Bill
Article
Cyclosporin-A improves management of SJS/TEN
Palm Beach, Fla. - Low-pulse cyclosporin-A is a promising treatment for Stevens-Johnson syndrome (SJS) and toxic epidermal necrolysis (TEN), Sabra Sullivan, M.D., chief of dermatology, University of Mississippi (Jackson) Medical Center, reported the annual meeting of the Noah Worcester Dermatological Society.
Related Videos
Related Content
